Single Platelet Rich Plasma Glottic Injections in Vocal Pathology Demonstrate Long Term Benefits

单次富血小板血浆声门注射治疗声带疾病显示出长期疗效

阅读:1

Abstract

OBJECTIVES: Platelet rich plasma (PRP) injection of the vocal folds (VF) is increasingly recognized as beneficial for VF pathologies. We examined how the number of PRP injections impacted voice outcomes in patients with VF pathologies excluding malignancy. METHODS: Patients undergoing PRP VF injections were followed prospectively (1, 3, 6, and 12 months) with examination, perceptual ratings, videostroboscopy, and completed questionnaires (Voice Handicap Index-10 [VHI-10], Vocal Fatigue Index [VFI]), rating improvement, and willingness to repeat PRP injection. Patients underwent between 1 and 7 PRP injections under local anesthetic in the office. Comparison of outcomes for single versus multiple doses of PRP was undertaken. RESULTS: Eighty-three individuals (60% female) received 123 PRP injections. Fifty-four participants (65%) had single injections, and 29 had 2-7 injections. Mean difference between pre-injection and 12-month VHI-10 for single and multiple injections was reduction of 6.95 (SD 4.8) and 8.2 (SD 13.4) respectively. There was no statistically significant difference in change in VHI-10 from baseline to 12 months (p = 0.71), 6 months (p = 0.74), or 3 months (p = 0.23) comparing single versus multiple injection groups. There was no difference in "improvement of VHI-10" or VFI between single versus multiple injection groups. Individuals with VF scar or previous procedures were more likely to require more than one PRP injection. CONCLUSION: Single PRP injection of the VF can provide significant improvement in vocal parameters in individuals with benign VF pathology out to 12 months. Additional PRP injections following an index injection should be considered on a case-by-case basis for patients where initial effects fade or additional benefit is desired.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。